1
|
Aduwo JY, Kanani SP, Kapadia S, Kim DW, Chapman TR, Chawla AK, Choe KS, Eblan MJ, Rao AD. Stereotactic Body Radiation Therapy and High-Dose Rate Brachytherapy Boost in Combination with Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Cohort Study. Int J Radiat Oncol Biol Phys 2023; 117:e362. [PMID: 37785245 DOI: 10.1016/j.ijrobp.2023.06.2452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The use of dose-escalated external beam radiation (EBRT) and brachytherapy (BT) boost with ADT has emerged as an option with superior biochemical control compared to dose-escalated EBRT alone. BT is traditionally delivered using low-dose rate techniques, but more recently high-dose rate (HDR) BT has also emerged as a boost option for these patients with promise of low toxicity rates. SBRT is a favorable modality for monotherapy for low and intermediate risk group patients, however its safety and efficacy as a boost in combination with EBRT is less well understood. The aim of this study is to compare SBRT boost, HDR boost and LDR boost for localized prostate cancer. MATERIALS/METHODS A single-institution retrospective chart review was performed of men receiving EBRT delivered using intensity modulated RT and either SBRT boost (650cGy x 3), HDR-BT boost (1500cGy x 1), or LDR boost with I-125 (110Gy). Of patients treated w/ SBRT boost, 39 (80%) were treated with an SIB to the MRI-detectable lesion(s) to 700cGy x 3. Treatment characteristics for each strategy were reviewed and on-treatment toxicity outcomes for each of the cohorts were compared using Chi-square tests. RESULTS From 2017-2022, 49 patients were treated with EBRT+SBRT boost, 44 patients received EBRT+ HDR-BT boost, and 46 patients received EBRT+ LDR-BT boost. The average age of patients included in the study was 71.2 years (median age 69.55 years, range 51.42-83.70 years) with average baseline PSA of 11 (median 7.6, range 3.3-64). In addition, 55% of the patients had high-risk/very high-risk disease, 39% had unfavorable intermediate disease and 6% had favorable intermediate disease. 139 patients received androgen deprivation therapy (93%). There were no differences in these baseline demographics and clinical or treatment factors between SBRT, HDR and LDR boost (p>0.05). The median dose/fx of EBRT was 4500cGy/25 fx (range 4500-5040cGy/23-28 fractions). At the end of treatment, 69% of the patients had 0-1 change in nocturia. There is an increase in nocturia episodes of 2-3 from baseline in 27% of the patients, while 4% had an increase in nocturia episodes of 4 or more from baseline with no difference between the SBRT, HDR and LDR boost. At baseline 36 patients (26%) reported urinary frequency symptoms, increasing to 80 patients (58%) by end of treatment with no difference between the SBRT, HDR and LDR boost. Similarly, there was a trend to increased use of urinary modifiers at end of treatment in patients treated with EBRT+HDR boost compared to EBRT+SBRT and EBRT+ LDR boost (89% vs. 71% v 72% respectively). CONCLUSION There was no significant difference in acute urinary toxicity and nocturia between SBRT, HDR and LDR boost (p>0.05).
Collapse
Affiliation(s)
- J Y Aduwo
- National Institutes of Health, Bethesda, MD; The Ohio State University College of Medicine, Columbus, OH
| | - S P Kanani
- Inova Schar Cancer Institute, Fairfax, VA
| | - S Kapadia
- Inova Schar Cancer Institute, Fairfax, VA
| | - D W Kim
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
| | - T R Chapman
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
| | | | - K S Choe
- Radiation Oncology Associates, Inova Schar Cancer Institute, Fairfax, VA
| | - M J Eblan
- UNC Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC
| | - A D Rao
- Inova Schar Cancer Institute, Fairfax, VA
| |
Collapse
|
2
|
Kanaan C, Layoun H, Kondoleon N, Mirzai S, Fadel R, Schold J, Arrigain S, Mehdi AM, Taliercio JT, Unai S, Kapadia S, Harb S, Nakhoul G. Comparison of CT acquired valvular calcification scores in hemodialysis vs peritoneal dialysis patients undergoing open heart surgery. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Several factors have been identified as independent risk factors for cardiac valvular calcification (CVC), including but not limited to age, inflammatory conditions, loss of calcification inhibitors, and dysregulated bone mineral metabolism. However, data is scarce regarding which dialysis modality portends more severe CVC.
Purpose
Our aim was to compare the degree of valvular calcification in hemodialysis (HD) and peritoneal dialysis (PD) patients prior to open heart surgery (OHS) using a computed CT calcium score.
Methods
Dialysis patients who underwent OHS at our institution from 2009–2019 who had a pre-surgical cardiac CT were grouped according to duration of dialysis modality prior to their surgical date. There were two study cohorts to evaluate outcomes of interest: mitral and aortic calcification. We included the first surgical record per patient for patients undergoing isolated CABG, or CABG+valve surgery (repair or replacement), or valve-only surgery (repair or replacement). To evaluate mitral calcification, we excluded any patients undergoing any mitral valve surgery (repair or replacement). We also excluded patients with a history of mitral valve repair/replacement. To evaluate aortic calcification, we excluded any patients undergoing any aortic valve surgery (repair or replacement). We also excluded patients with a history of aortic valve repair/replacement. Mitral annular and aortic valvular calcification were assessed using the Agatston score. Logistic regression was performed to test for the association of PD and HD cumulative dialysis duration with presence of valvular calcification.
Results
A total of 296 patients met inclusion criteria for at least one of the strata in our study. Of those, 214 met inclusion for the mitral strata, and 166 met criteria for the aortic strata (Table 1). In the logistic regression model for the mitral strata, age and female sex were associated with higher odds of presence of mitral calcification (Figure 1). Cumulative years on PD and cumulative years on HD were not significantly associated with presence of mitral calcification. In the logistic regression model for the aortic strata, age was associated with higher odds of presence of aortic calcification, while female sex was associated with lower odds (Figure 1). Cumulative years on PD and cumulative years on HD were not significantly associated with presence of aortic calcification.
Conclusion
Presence of mitral and aortic calcification for patients undergoing OHS was not significantly associated with cumulative length of PD or HD after adjusting for age and gender, suggesting that there may be more factors at play in the progression of valvular calcification in end stage renal disease patients than what was previously thought.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Kanaan
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - H Layoun
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - N Kondoleon
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Mirzai
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - R Fadel
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - J Schold
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Arrigain
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - A M Mehdi
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - J T Taliercio
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Unai
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Kapadia
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Harb
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - G Nakhoul
- Cleveland Clinic Foundation , Cleveland , United States of America
| |
Collapse
|
3
|
Abadie B, Held M, Puri R, Krishnaswamy A, Yun J, Hanna M, Reed G, Kapadia S, Jaber W. Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The approval of new therapies for treating transthyretin (TTR) cardiac amyloidosis has led to significant interest in identifying patients at high risk for this disease. Investigators have identified a correlation between severe degenerative aortic stenosis (AS) and TTR cardiac amyloidosis in older patients, with several studies finding up to 20% of patients who undergo transcatheter aortic valve replacement (TAVR) having TTR cardiac amyloidosis. These initial TAVR studies were conducted when TAVR was performed almost exclusively in high surgical risk populations. Therefore, the true incidence of TTR cardiac amyloidosis in an all-comers with severe degenerative AS referred for TAVR is unknown.
Purpose
To identify the true burden of TTR cardiac amyloidosis in a contemporary population of severe degenerative AS undergoing TAVR screening.
Methods
All patients ≥70 years with severe native valve degenerative AS seen in a multidisciplinary valve clinic were referred for technetium-99m pyrophosphate cardiac scintigraphy (PYP scan) for evaluation of cardiac amyloidosis. Diagnosis was made via combination of planar grade and heart to contralateral lung ratio, confirmed on single positron emission computed tomography/computed tomography (SPECT/CT). Patients with a positive PYP scan were referred to a heart failure clinic where they underwent testing for AL amyloidosis.
Results
Over a 10 month period, 247 patients seen in valve clinic underwent a PYP scan. Of this cohort, 203 patients ultimately underwent TAVR, 15 surgical aortic valve replacement, and 2 balloon valvuloplasty with 27 patients having not yet undergone a procedure. The positivity rate was 4% (10/247) with 1 patient having an equivocal result. The patients with a positive PYP scan had higher rate of low-flow low-gradient (LFLG) AS (64% vs 29%, p=0.006) and classical LFLG AS (27% vs 8%, p=0.02). Echocardiographic measures associated with a positive PYP scan include a lower global longitudinal strain (−10.0% vs −16.1%, p=0.008), lower average e' (4.5 vs 6.5, p=0.003), and an increased E/A ratio (1.8 vs 1.1, p=0.018).
Conclusions
The incidence of TTR amyloidosis in a contemporary, severe AS population ≥70 years undergoing TAVR screening appears much lower than previously described in the literature. Echocardiographic traits may be able to predict which patients with severe AS should undergo evaluation for TTR cardiac amyloidosis.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- B Abadie
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - M Held
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - R Puri
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - J Yun
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - M Hanna
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - G Reed
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - S Kapadia
- Cleveland Clinic Foundation , Cleveland , United States of America
| | - W Jaber
- Cleveland Clinic Foundation , Cleveland , United States of America
| |
Collapse
|
4
|
Lehenbauer K, Asch F, Weissman NJ, Grayburn P, Kar S, Lim S, Li D, Puri R, Kapadia S, Sannino A, Lindenfeld J, Abraham W, Mack MJ, Stone GW, Hahn R. Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
OnBehalf
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT)
Background
Prior studies suggest tricuspid regurgitation (TR) diminishes/resolves following mitral valve surgery and thus do not require treatment and may not influence outcomes.
Purpose
We sought to evaluate the change in TR (ΔTR) and its association with outcomes after transcatheter edge-to-edge repair (TEER) compared with guideline-directed medical therapy (GDMT) in the COAPT trial.
Methods
Patients from the COAPT trial with echo core lab TR assessment at baseline and 30-day follow-up (n = 504) were included and divided into 2 groups: those whose TR worsened (ΔTR-INC) and those with no change or improvement in TR (ΔTR-SAME/DEC). Two-year composite endpoints of death or heart failure hospitalization (HFH) and the individual components were analyzed, after excluding events occurring within the first 30 days.
Results
ΔTR-SAME/DEC occurred in 430 pts (228 TEER, 202 GDMT) while ΔTR-INC was noted in 74 pts (38 TEER, 36 GDMT) (Figure 1A). From 30 days to 2 years, ΔTR-INC pts had a higher rate of the composite outcome of death or HFH compared with ΔTR-SAME/DEC (p = 0.006, Figure 1B). Both 2-year death (HR 1.52, 95% CI 1.01-2.27; p = 0.04) and HFH (HR 1.52, 95% CI 1.04-2.22; p = 0.03) were associated with ΔTR-INC. Assessed by treatment group (Figure 1C and 1D), the relationship between ΔTR-INC and composite death or HFH was significant in GDMT alone pts (HR 1.86, 95% CI 1.21-2.86) but not in TEER pts (HR 1.33, 95% CI 0.79-2.23), although interaction testing demonstrated consistency between the two treatments (Pint = 0.31).
Conclusions
Worsening TR at 30 days occurred in ∼15% of pts in the COAPT trial whether they were treated with TEER or GDMT alone. DTRINC was associated with increased death and HFH during 2-year follow-up. Abstract Figure 1
Collapse
Affiliation(s)
- K Lehenbauer
- Columbia University Medical Center, New York, United States of America
| | - F Asch
- Medstar Research Institute, Washington, DC, United States of America
| | - NJ Weissman
- Medstar Research Institute, Washington, DC, United States of America
| | - P Grayburn
- Baylor Scott & White Health, Plano, United States of America
| | - S Kar
- Los Robles Health System, Los Angeles, United States of America
| | - S Lim
- University of Virginia, Charlottesville, United States of America
| | - D Li
- Cardiovascular Research Foundation, New York, United States of America
| | - R Puri
- Cleveland Clinic, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic, Cleveland, United States of America
| | - A Sannino
- Baylor Scott & White Health, Plano, United States of America
| | - J Lindenfeld
- Vanderbilt University Medical Center, Nashville, United States of America
| | - W Abraham
- Ohio State University Wexner Medical Center, Columbus, United States of America
| | - MJ Mack
- Baylor Scott & White Health, Plano, United States of America
| | - GW Stone
- Icahn School of Medicine at Mount Sinai, New York, United States of America
| | - R Hahn
- Columbia University Medical Center, New York, United States of America
| |
Collapse
|
5
|
Lak H, Sammour Y, Chahine J, Chawla S, Kadri A, Popovic Z, Tarakji K, Svensson LG, Reed G, Puri R, Krishnaswamy A, Kapadia S. Impact of new-onset left bundle branch block on clinical and echocardiographic outcomes after TAVR with SAPIEN-3 valve. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
New left bundle branch block (LBBB) is a common finding after transcatheter aortic valve replacement (TAVR) that can result in worse outcomes after TAVR. We aim to investigate the impact of new-onset LBBB after TAVR using the SAPIEN-3 (S3) valve.
Methods
Consecutive patients who underwent transfemoral-TAVR with S3 valve between April 2015 and December 2018 were included. Exclusion criteria included pre-existing LBBB, right bundle branch block, left anterior hemiblock, left posterior hemiblock, wide QRS ≥120 msec, prior permanent pacemaker (PPM), and non-transfemoral access.
Results
Among 612 patients, 11.4% developed new-onset LBBB upon discharge. Implantation depth was the only predictor of new-onset LBBB (OR 1.294; 95% CI 1.121–1.493; p<0.001). The median (IQR) length of stay was longer with new-onset LBBB [3 (2–5) days vs. 2 (1–3) days; p<0.001]. New-onset LBBB was associated with higher thirty-day PPM requirement (18.6% vs. 5.4%; p<0.001) including those implanted after discharge (4.3% vs. 0.9%; p=0.02). There was no difference in 3-year all-cause mortality between both groups (30.9% vs. 30.6%; log-rank p=0.829). Further, new-onset LBBB was associated with lower left ventricular ejection fraction (LVEF) at both 30 days (55.9±11.4% vs. 59.3±9%; p=0.026) and 1 year (55±12% vs. 60.1±8.9%; p=0.002) despite no differences at baseline. These changes were still present when we stratified patients according to baseline LVEF (≥50% or <50%). We also noted higher mean LV end-diastolic volume index (51.4±18.6 vs. 46.4±15.1 ml/m2; p=0.036), and LV end-systolic volume index (23.2±14.1 vs. 18.9±9.7 ml/m2; p=0.009) with new-onset LBBB at 1 year. Lastly, there were significantly higher rates of heart failure readmissions at 1 year with new-onset LBBB (10.7% vs. 4.4%; log-rank p=0.033).
Conclusion
Among our cohort of S3 recipients, new-onset LBBB was associated with higher PPM requirement, worse LVEF, higher LV volumes and increased risk of heart failure hospitalizations. However, it did not affect mortality in the short-to-intermediate post-TAVR period.
Funding Acknowledgement
Type of funding sources: None. Figure 1. All-cause Survival
Collapse
Affiliation(s)
- H Lak
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Y Sammour
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - J Chahine
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Chawla
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Kadri
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Z Popovic
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - K Tarakji
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - L G Svensson
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - G Reed
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R Puri
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
6
|
Lak H, Sammour Y, Chawla S, Svensson LG, Yun J, Harb S, Reed GW, Puri R, Jaber W, Krishnaswamy A, Kapadia S. Impact of doppler velocity index after transcatheter aortic valve replacement using Sapien-3 valve – a single centre experience. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Little is known about the hemodynamic performance of Edwards Sapien-3 (S3) valve after Transcatheter Aortic Valve Replacement (TAVR). Doppler velocity index (DVI) is a better indicator of prosthetic valve function as it is independent of valve size and flow, unlike mean gradient and peak velocity which are flow-dependent.
Methods
In this study, we compare outcomes based on differences in DVI among a consecutive series of patients who underwent S3 TAVR between April 2015 and December 2018. Our institutional review board approved the study and informed consents were obtained from the subjects.
Results
Among 921 patients who had follow-up echocardiograms within 30 days after TAVR, 60.8% had DVI ≤0.5, while 39.2% had DVI >0.5. The median 30-day DVI was 0.47 with a standard deviation of 0.11 and mean 0.49 and interquartile range 0.41–0.55. The baseline clinical and procedural characteristics were similar between both groups with the exception of less post-dilation (36.8% vs. 47.4%; p=0.001) and greater implantation depth (2.59±1.99 vs. 2.31±1.9mm; p=0.031) with DVI ≤0.5. The rates of aortic valve calcification, pre dilation, pre-TAVR aortic regurgitation (AR) were similar. At baseline, there were no differences between both groups in mean or peak gradients or aortic velocity time integral (VTI). At 1 year, mean gradients were higher with DVI ≤0.5 (12.7±5.6 vs. 11.1±4.6 mmHg; p=0.001). DVI ≤0.5 was associated with higher peak gradients (24.2±10.2 vs. 21.4±8.7 mmHg; p=0.002), and aortic VTI (51.4±13.5 vs. 46.8±12.2 cm; p<0.001) at 1 year, especially with the 26mm and 29mm prostheses. Compared with DVI>0.5 group, patients in DVI<0.5 group had lower baseline left ventricular ejection fraction (LVEF) (54.5±12.2% vs. 58.9±11.2%; p<0.001), higher left ventricular end-diastolic volume index (LVEDVi) (54.3±20.9 vs. 49.4±17.4 ml/m2; p=0.001), higher LV end-systolic volume index (LVESVi) (25.2±16.5 vs. 21.3±12.7 ml/m2; p=0.001), and similar LV mass index (110.7±31.9 vs. 106.9±32.7 g/m2; p=0.134). 1-year mortality rates among patients who had DVI ≤0.5 compared to DVI >0.5 were lower (6.6% vs. 10.6%; log-rank p=0.033), however no difference was noted at both 2 years (17.3% vs. 20.1%; log-rank p=0.151), and 3 years after TAVR (30.7% vs. 31.2%; log-rank p=0.333).
Conclusions
DVI<0.5 was associated with higher peak gradients and lower baseline LVEF. DVI <0.5 group patients had lower 1-year mortality but similar mortality at 2 and 3-years of follow up.
Funding Acknowledgement
Type of funding sources: None. Figure 1. All-cause SurvivalFigure 2. Hemodynamic Data
Collapse
Affiliation(s)
- H Lak
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Y Sammour
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Chawla
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - L G Svensson
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - J Yun
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Harb
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - G W Reed
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R Puri
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - W Jaber
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
7
|
Lak H, Sammour Y, Chawla S, Gajulapalli RD, Kumar A, Parikh P, Svensson LG, Harb S, Tarakji K, Wazni O, Reed GW, Puri R, Krishnaswamy A, Kapadia S. Impact of pacing-related differences on clinical and echocardiographic outcomes after TAVR with SAPIEN-3 valve. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Data regarding the impact of pacing on outcomes after transcatheter aortic valve replacement (TAVR) is evolving especially with regards to pre-existing PPM. We examined the impact of new and prior PPM on clinical and hemodynamic outcomes after SAPIEN-3 (S3) TAVR.
Methods
Consecutive patients who underwent transfemoral-TAVR using S3 valve between April 2015 and December 2018 at our Clinic were included.
Results
Among 1028 patients, 10.2% required new PPM within 30 days, while 14% had pre-existing PPM. The presence of either prior or new PPM had no impact on 3-year mortality (log-rank p=0.6), or 1-year major adverse cardiac and cerebrovascular event (MACCE) (log-rank p=0.65). New PPM was associated with lower left ventricular ejection fraction (LVEF) at both 30 days (54.4±11.3% vs. 58.4±10.1%; p=0.001), and 1 year (54.2±12% vs. 59.1±9.9%; p=0.009) compared to no PPM. Similarly, prior PPM was associated with worse LVEF at 30 days (53.6±12.3%; p<0.001) and 1 year (55.5±12.1%; p=0.006) compared to no PPM. Interestingly, new PPM was associated with lower 1-year mean gradient (11.4±3.8 vs. 12.6±5.6 mmHg; p=0.04), and peak gradient (21.3±6.5 vs. 24.1±10.4 mmHg; p=0.01) despite no baseline differences. Prior PPM was also associated with lower 1-year mean gradient (10.3±4.4 mmHg; p=0.001), and peak gradient (19.4±8 mmHg; p<0.001), and higher doppler velocity index (0.51±0.12 vs. 0.47±0.13; p=0.039). Moreover, 1-year LV end-systolic volume (LVESVi) was higher with new (23.2±16.1 vs. 20±10.8 ml/m2; p=0.038), and prior PPM (24.5±19.7; p=0.038) compared to no PPM. Prior PPM was associated with higher moderate-to-severe tricuspid regurgitation (35.3% vs. 17.7%; p<0.001). There were no differences with regards to the rest of the studied echocardiographic outcomes at 1 year.
Conclusion
In this S3 cohort, new and prior PPM did not affect 3-year mortality or 1-year MACCE, however they were associated with worse LVEF, higher LVESVi and lower mean and peak gradients on follow-up compared to no PPM.
Funding Acknowledgement
Type of funding sources: None. Figure 1. All-cause Survival
Collapse
Affiliation(s)
- H Lak
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Y Sammour
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Chawla
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R D Gajulapalli
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Kumar
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - P Parikh
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - L G Svensson
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Harb
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - K Tarakji
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - O Wazni
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - G W Reed
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R Puri
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
8
|
Lak H, Chawla S, Verma B, Vural A, Gad M, Shekhar S, Nair R, Yun J, Burns D, Puri R, Reed G, Harb S, Krishnaswamy A, Kapadia S. Outcomes of transfemoral-transcatheter aortic valve replacement with Sapien-3 valve in liver cirrhosis patients. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Little is known about the outcomes of liver cirrhosis patients with severe aortic stenosis (AS) who undergo transcatheter aortic valve replacement (TAVR).
Methods
We undertook a retrospective analysis of consecutive patients with severe symptomatic AS who underwent transfemoral-TAVR with Sapien-3 valve at our Clinic between April 2015 and December 2018, yielding 32 patients with liver cirrhosis on imaging including ultrasound and/or computed tomography. Their baseline characteristics, procedural and long-term outcomes after TAVR with the non-cirrhotic group were compared, along with their management strategies as per the hepatology team.
Results
Among 1028 patients, 32 were assigned to the cirrhosis, and 996 were assigned to the non-cirrhosis (control) group. Compared with the control group cirrhotic patients were slightly younger in age (74.5 vs 81.2 years), had a slightly higher BMI (31.3 vs 29.3), and had a higher incidence of prior history of myocardial infarction (38% vs 33%). Baseline variables including the history of smoking, hypertension, diabetes, and atrial fibrillation were comparable in both groups. Among cirrhotic patients (n=32), the most common etiologies were non-alcoholic steatohepatitis (NASH) (37.5%), Alcoholism (18.75%), and Hepatitis C (12.5%). The mean MELD-NA score was 11.8 and 67% of patients were Child PUGH Class A and 33% were Child PUGH Class B and all patients had a Child PUGH score of ≥5. 53% of patients (n=17) in the cirrhosis group were evaluated by Hepatology and 12.5% (n=4) were evaluated for a liver transplant but only 1 patient had a liver transplant post-TAVR. Compared with the control group cirrhotic patients had similar 1-year mortality (12% vs 12%, p=1), had a lower rate of 30-day new pacemaker post tavr (6% vs 9% p=0.85), had a higher rate of 1-year readmission for heart failure (12% vs 5% p=0.12) and similar 1-year major adverse cardiac and cerebrovascular event (MACCE) rate (15% vs 14% p=0.98)
Conclusion
Patients with severe AS undergoing TAVR with concomitant liver cirrhosis demonstrate comparable outcomes compared with their non- cirrhotic counterparts. NASH followed by alcoholic cirrhosis was found to be most common etiology.
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- H Lak
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Chawla
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - B Verma
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Vural
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Gad
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Shekhar
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R Nair
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - J Yun
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - D Burns
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - R Puri
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - G Reed
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Harb
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
9
|
Lee YWJ, Kapadia S, Butterworth C, Thomas P, Smith P. Restorative Rehabilitation of the Cleft Affected Occlusion - A Service Evaluation. Eur J Prosthodont Restor Dent 2021; 30:49-54. [PMID: 33848409 DOI: 10.1922/ejprd_2210lee06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Cleft Lip and/or Palate (CLP) is the most common cranio-facial abnormality thought to be caused by a combination of genetic and environmental factors causing challenges with feeding, dental development and speech. Cleft affected individuals often present a unique set of challenges with regards to their oro-facial and dental development and require multidisciplinary care. This article aims to describe the role of the restorative dentist in the multidisciplinary management of cleft affected individuals and outlines the various clinical presentations and restorative challenges. This article describes the various treatment modalities provided for cleft affected individuals under the National Health Service (NHS) at Liverpool University Dental Hospital (LUDH) and ranges from minimally invasive techniques to conventional fixed and removable prosthodontics.
Collapse
Affiliation(s)
- Y W J Lee
- Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK
| | - S Kapadia
- Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK
| | - C Butterworth
- Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK
| | - P Thomas
- Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK
| | - P Smith
- Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK
| |
Collapse
|
10
|
Kapadia S, Krishnaswamy A, Wierup P, Schoenhagen P, Harb S. Tricuspid Annulus Three-dimensional Geometry And Dimensions In Normal, Degenerative, And Functional Mitral Regurgitation. J Cardiovasc Comput Tomogr 2020. [DOI: 10.1016/j.jcct.2020.06.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Kapadia S, Krishnaswamy A, Wierup P, Schoenhagen P, Harb S. Mitral Annulus Three-dimensional Configuration And Size In Normal, Degenerative, And Functional Mitral Regurgitation. J Cardiovasc Comput Tomogr 2020. [DOI: 10.1016/j.jcct.2020.06.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
12
|
Dhariya S, Udayawar A, Kapadia S, Shivdasani B. Wolf Parkinson White Syndrome- Radiofrequency Ablation in 5 Yr. Old Child. Indian Heart J 2019. [DOI: 10.1016/j.ihj.2019.11.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
13
|
Kapadia S, Udayvar A, Dhariya S, Survade H. Deadly Pacemaker Related Infection- Treated By New Technique of Lead Extraction. Indian Heart J 2019. [DOI: 10.1016/j.ihj.2019.11.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Karrthik A, Gad M, Bazarbashi N, Ahuja K, Kaur M, Sammour Y, Kapadia S, Abdallah M. P6438Trends of acute kidney injury following percutaneous coronary interventions. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Acute kidney injury (AKI) is a significant in-hospital complication in patients undergoing percutaneous coronary interventions (PCI) and has been shown to be associated with poor outcomes. Prior studies have shown an upward trend of AKI post PCI which may be related to a multitude of factors. In this study, we aim to discern whether the recent changes in AKI definition, awareness of risk calculators, and preventive measures have been effective in changing the inclining trend.
Methods
Patients who underwent PCI during hospitalization were identified retrospectively in the Nationwide Readmission Database (NRD) from January 2010 to December 2014. All patients older than 18 years were included in the current study. Patient demographics and comorbidities were identified using appropriate ICD-9 codes. The primary outcome is the temporal trends of AKI following PCI and secondary outcomes are temporal trends in mortality, length of stay and hospitalization cost in patients with AKI. Continuous variables were expressed as means ± standard deviation or median (IQR), and categorical variables were expressed as percentages (%). All statistical tests were two-sided.
Results
Among the 2,712,473 patients who underwent PCI from 2010 to 2014, 162,286 (6%) patients developed AKI post PCI. Mean age was 69.22±12.34 years and 65% of them were males. The percentage of cases with AKI rose almost twofold from 2010 to 2014 (4.8% to 8.1%, p-value <0.005), despite the lack of a significant change in patient's demographics and comorbidities over the years. Among patients with a history of Chronic Kidney Disease (CKD) the incidence of AKI increased from 20.3% to 24.2%, and in patients without CKD history the incidence of AKI almost doubled (2.6% to 5.0%) from 2010 to 2014. There was a slight decrease in in-hospital mortality (9.4% to 8.8%) and median length of stay (7 days to 5 days), and a slight increase in the mean cost of hospitalization ($124,755.1 to $133,902.17) from 2010 to 2014.
AKI Incidence and mortality trend
Conclusion
This large cohort study shows a consistent uptrend of AKI in patients undergoing PCI from 2010 to 2014. Despite this, the mortality and length of stay are decreasing while the cost of hospitalization only slightly increased in patients with AKI. Thus, future drives to implement renal protective measures and advanced studies to identify new preventive therapies are needed to reduce the incidence of AKI post-PCI.
Collapse
Affiliation(s)
- A Karrthik
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Gad
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - N Bazarbashi
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - K Ahuja
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Kaur
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Y Sammour
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Abdallah
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
15
|
Karrthik A, Gad M, Bazarbashi N, Ahuja K, Sammour Y, Kaur M, Ahmed H, Kapadia S. P5331Aspirin use for prevention of cardiovascular events in patients with high lipoprotein(a): a population-based study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0300] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
High lipoprotein(a) [Lp(a)] levels have been shown to increase Myocardial Infarction (MI) and all-cause mortality. However, studies evaluating the optimal preventive measures for that subset of cardiac patients are scarce. This study aims to study the outcomes of aspirin use versus no aspirin for the prevention of all-cause mortality and myocardial infarction in patients with high Lp(a) levels.
Purpose
We sought to determine the effect of Aspirin in reducing the rate of MI and all-cause mortality among patients with high lipoprotein(a) [Lp(a) ≥50mg/dL]
Methods
Patients who attended the preventive cardiology clinic from 2005 to 2016 and included in the Preventive Cardiology Database were included in the current single-center, retrospective, observational cohort study that was conducted according to the guidelines of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology Statement) checklist. The primary outcome was the incidence of myocardial infarction and the secondary outcome was all-cause mortality. Patients were excluded in cases of I) Lp(a)a <50mg/dL, II) history of malignancy, or III) being on anticoagulation/ dual antiplatelet therapy. The median duration of follow-up was 92 months from time of Lp(a) measurement to the last follow-up. Continuous variables were expressed as means ± standard deviation or median (IQR), and categorical variables were expressed as percentages (%). All statistical tests were two-sided. A propensity score-matched analysis was performed with 1:1 nearest match for Age, Gender, Race, Smoking status, BMI, Diabetes, Peripheral artery disease, Carotid artery disease, coronary artery disease, chronic kidney disease, Heart failure, Hypertension, Dyslipidemia, Stroke, family history of coronary artery disease, Lp (a), LDL, HDL, Triglycerides, glucose and total cholesterol.
Results
1,805 patients fulfilled the inclusion and exclusion criteria out of 7,410 patients initially identified with recorded Lp(a) levels in the Preventive Cardiology Database. Of these, 376 patients were taking aspirin, and 1429 patients were not receiving aspirin. After propensity score matching for different baseline characteristics and comorbidities as mentioned above, 316 patients were matched in each group. Patients who were on Aspirin had a significantly lower rate of MI events compared to patients who were not on aspirin (6.96% vs 12.02%, P=0.03) and a lower rate, however statistically non-significant, of all-cause mortality (2.84% vs 4.11%, P=0.385).
Conclusion
The use of aspirin in patients with elevated Lp(a) levels significantly lowers the rate of myocardial infarction events. Larger randomized clinical trials are warranted to evaluate the use of aspirin for primary and secondary prevention of major adverse cardiovascular events in patients with high Lp(a) levels.
Collapse
Affiliation(s)
- A Karrthik
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Gad
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - N Bazarbashi
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - K Ahuja
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - Y Sammour
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - M Kaur
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - H Ahmed
- Cleveland Clinic Foundation, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Cleveland, United States of America
| |
Collapse
|
16
|
Sato K, Sankaramangalam K, Krishnaswamy A, Mick S, Rodriguez L, Grimm R, Menon V, Kapadia S, Desai M, Svensson L, Griffin B, Popovic Z. 1139Prognostic impact of aortic valve replacement in contemporary low-gradient aortic stenosis patients with lack of contractile reserve. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.1139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Sato
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - K Sankaramangalam
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - A Krishnaswamy
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - S Mick
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - L Rodriguez
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - R Grimm
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - V Menon
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - S Kapadia
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - M Desai
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - L Svensson
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - B Griffin
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| | - Z Popovic
- Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, United States of America
| |
Collapse
|
17
|
Yip JLY, Kapadia S, Ahmed A, Millership S. Outbreaks of influenza-like illness in care homes in the East of England: impact of variations in neuraminidase inhibitor provision. Public Health 2018; 162:98-103. [PMID: 29990618 DOI: 10.1016/j.puhe.2018.05.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 05/29/2018] [Accepted: 05/31/2018] [Indexed: 10/28/2022]
Abstract
OBJECTIVES To examine the differences in outcomes related to variable provision of antivirals in care home respiratory outbreaks. STUDY DESIGN This is a retrospective observational study. METHODS Routinely collected outbreak surveillance data reported from care home staff was recorded using a standard template and extracted from the Public Health England health protection electronic records. Data included numbers of people affected, provision of oseltamivir, hospitalization, and deaths during the outbreak in the care home. Oseltamivir provision was categorized by proportion of eligible residents prescribed it on advice. Additional data on microbiological diagnoses were obtained directly from the hospital laboratories. Logistic regression was used to examine associations between oseltamivir provision and hospitalizations and deaths in care homes. RESULTS One hundred and sixty-eight outbreaks were reported from 28th July 2016 until 27th March 2017, affecting 1459 residents and 347 staff. There were 76 hospital admissions and 37 deaths overall. Although deaths and hospital admissions also occurred in outbreaks caused by other respiratory viruses, outbreaks caused by influenza had the highest median number of people affected and a greater proportion of hospital admissions and deaths. Of the 56 outbreaks caused by influenza, there was a significant increase in the odds of the care home reporting deaths when oseltamivir was not used (odds ratio = 8.15, 95% confidence interval = 1.38-48.20, P = 0.02). There were also non-significant reductions in duration of outbreak and hospital admissions in care home outbreaks with oseltamivir treatment. CONCLUSIONS Partial or no provision of oseltamivir was associated with poorer outcomes in laboratory-confirmed influenza outbreaks.
Collapse
Affiliation(s)
- J L Y Yip
- Public Health England, East of England Centre, Victoria House, Capital Park, Fulbourn, Cambridge CB21 5XA, UK; Clinical Research Unit, Infectious and tropical Diseases Department, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK
| | - S Kapadia
- East of England Health Protection Team, Goodman House, Station Approach, Harlow, CM20 2ET, UK
| | - A Ahmed
- Public Health England, East of England Centre, Victoria House, Capital Park, Fulbourn, Cambridge CB21 5XA, UK
| | - S Millership
- East of England Health Protection Team, Goodman House, Station Approach, Harlow, CM20 2ET, UK.
| |
Collapse
|
18
|
Kapadia S, Bazzali J, Leung W, Guth H, Millership S. Panton-Valentine-producing Staphylococcus aureus: what happens to patients after skin decolonization in the community? J Hosp Infect 2018; 100:359-360. [PMID: 29577992 DOI: 10.1016/j.jhin.2018.03.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2018] [Accepted: 03/19/2018] [Indexed: 10/17/2022]
Affiliation(s)
- S Kapadia
- Public Health England East of England Health Protection Team, Harlow, UK
| | - J Bazzali
- Public Health England East of England Health Protection Team, Harlow, UK
| | - W Leung
- Public Health England East of England Health Protection Team, Harlow, UK
| | - H Guth
- Public Health England East of England Health Protection Team, Harlow, UK
| | - S Millership
- Public Health England East of England Health Protection Team, Harlow, UK.
| |
Collapse
|
19
|
Sato K, Kumar A, Jones B, Mick S, Desai M, Griffin B, Kapadia S, Popovic Z. P6338Prognostic impact of B-type natriuretic peptide after transcatheter aortic valve replacement in patients with severe aortic stenosis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p6338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
Faggioni M, Baber U, Sartori S, Kini A, Rao S, Weintraub W, Henry T, Kapadia S, Muhlestein J, Toma C, Effron M, Defranco A, Baker B, Pocock S, Mehran R. P493Impact of prior cerebrovascular diseases on treatment strategies and clinical outcomes after percutaneous coronary interventions. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Ayach B, Cordova F, Kapadia S, Tuzcu M. UTILITY OF NT-proBNP LEVELS IN PREDICTING THE SEVERITY OF AORTIC STENOSIS IN MEN. Can J Cardiol 2015. [DOI: 10.1016/j.cjca.2015.07.288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
22
|
Forster D, Kapadia S, McGinley S, Mellor N. 26CAN PATIENTS USE AND ACCESS THEIR CALL BELL? IMPROVING PATIENTS COMMUNICATION OF THEIR NEEDS. Age Ageing 2015. [DOI: 10.1093/ageing/afv106.26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Rizwan MM, Chhabra G, Mishra A, Kapadia S, Rai R, Gill H. A case of isolated cutaneous Rosai-Dorfman-Syndrome. Gulf J Oncolog 2013; 1:87-89. [PMID: 23996873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/27/2013] [Indexed: 06/02/2023]
Abstract
UNLABELLED Rosai-Dorfman Syndrome (RDD) is a rare, benign, self-limiting disorder which is characterized by the non-malignant proliferation of distinctive histiocytic cell within lymphatic system. RDD has been described as a dynamic entity in the spectrum of histiocytosis with non-Langerhans cell histiocytosis at one end and Langerhans cell histiocytosis at the other. The exact etiology of this disease is uncertain despite widespread search for infectious or immunological reasons. We present a case of purely cutaneous Rosai-Dorfman Syndrome presenting as abdominal wall swelling. KEYWORDS Rosai-Dorfman Disease, Lymphoma.
Collapse
Affiliation(s)
- M M Rizwan
- Mian Muhammad Rizwan, Department of Internal Medicine, Prince George's Hospital, 3001 Hospital Drive, Cheverly, MD 20785; USA. , Tel. 001-240-330-0065, Fax: 001-301-618-2986
| | | | | | | | | | | |
Collapse
|
24
|
Andrews J, Puri R, Madden S, Madder R, Muller J, Wolski K, Kataoka Y, Uno K, King K, Tuzcu E, Kapadia S, Nicholls S. The Relationship Between Coronary Arterial Plaque Burden and Lipid Pools: Histological Validation Using Near-Infrared Spectroscopy and Intravascular Ultrasound. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
25
|
Wood D, Toggweiler S, Ye J, Cheung A, Leipsic J, Gurvitch R, Willson A, Binder R, Rodés-Cabau J, Kapadia S, Svensson L, Webb J. 142 Transcatheter valve-in-valve implantation for failed balloon expandable transcatheter aortic valves. Can J Cardiol 2011. [DOI: 10.1016/j.cjca.2011.07.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
26
|
|
27
|
Taylor J, Saveedra-Campos M, Harwood D, Pritchard G, Raphaely N, Kapadia S, Efstratiou A, White J, Balasegaram S. Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010. Euro Surveill 2010; 15:19634. [PMID: 20738991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023] Open
Abstract
We report on a case of toxigenic Corynebacterium ulcerans infection in a fully immunised veterinary student, investigated in London, United Kingdom, in May 2010. There was no ongoing transmission in human contacts. Possible animal sources were identified.
Collapse
Affiliation(s)
- J Taylor
- North East and North Central London Health Protection Unit, London, United Kingdom
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Taylor J, Saavedra-Campos M, Harwood D, Pritchard G, Raphaely N, Kapadia S, Efstratiou A, White J, Balasegaram S. Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010. Euro Surveill 2010. [DOI: 10.2807/ese.15.31.19634-en] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We report on a case of toxigenic Corynebacterium ulcerans infection in a fully immunised veterinary student, investigated in London, United Kingdom, in May 2010. There was no ongoing transmission in human contacts. Possible animal sources were identified.
Collapse
Affiliation(s)
- J Taylor
- North East and North Central London Health Protection Unit, London, United Kingdom
| | - M Saavedra-Campos
- North East and North Central London Health Protection Unit, London, United Kingdom
| | - D Harwood
- Veterinary Laboratories Agency, Itchen Abbas, Winchester, United Kingdom
| | - G Pritchard
- Veterinary Laboratories Agency, Rougham Hill, Bury St Edmunds, Suffolk, United Kingdom
| | - N Raphaely
- Thames Valley Health Protection Unit, Didcot, United Kingdom
| | - S Kapadia
- Essex Health Protection Unit, Witham, United Kingdom
| | - A Efstratiou
- Streptococcus and Diphtheria Reference Unit, Health Protection Agency Centre for Infections, London, United Kingdom
| | - J White
- Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency Centre for Infections, London, United Kingdom
| | - S Balasegaram
- North East and North Central London Health Protection Unit, London, United Kingdom
| |
Collapse
|
29
|
|
30
|
Wells K, Kapadia S, Cantrell B, Keigher K, Lopes D, Chen M. E-003 Initial experience with a 'timeout' designed for neuroendovascular procedures. J Neurointerv Surg 2010. [DOI: 10.1136/jnis.2010.003251.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
31
|
Bayturan O, Shao M, Lavoie A, Wolski K, Schoenhagen P, Kapadia S, Tuzcu E, Nissen S, Nicholls S. Abstract: P1386 LOWERING OF HBAIC IS ASSOCIATED WITH LESS PROGRESSION OF CORONARY ATHEROSCLEROSIS. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71394-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
32
|
Pettersson G, Yun J, Nocero J, Mason D, Murthy S, Kapadia S, Mangi A, Mehta A, Budev M. 116: Lung Transplantation with Direct Bronchial Arterial Revascularization (BAR): Feasible and Effective – Time To Revisit? J Heart Lung Transplant 2009. [DOI: 10.1016/j.healun.2008.11.794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
33
|
Sipahi I, Tuzcu EM, Moon KW, Nicholls SJ, Schoenhagen P, Zhitnik J, Crowe TD, Kapadia S, Nissen SE. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study. Heart 2008; 94:623-7. [DOI: 10.1136/hrt.2007.129965] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
34
|
Parakh R, Kapadia S, Agarwal S, Grover T, Bukhari S, Yadav A, Sen I, Pankaj P. Assessment of total thrombus load in symptomatic patients with venous thromboembolism. Clin Appl Thromb Hemost 2006; 12:369-72. [PMID: 16959693 DOI: 10.1177/1076029606291408] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Pulmonary embolism (PE) and Deep vein thrombosis (DVT) are separate but related aspects of the same dynamic process termed as venous thrombembolism (VTE). The existing Asian literature has shown a wide variation in the prevalence of VTE, with very limited data from the Indian subcontinent. Between January 2001 and July 2004, 1,552 patients with clinically suspected lower limb DVT underwent a combined ascending radionuclide venogram and lung perfusion scan for assessment of the total thrombus burden. Of 744 patients with radionuclide venography proven DVT, 294 (40%) had a high probability lung scan. Nearly half of these patients were asymptomatic for pulmonary embolism. The high prevalence of PE in patients with DVT suggests the need for evaluation of thrombus load in the venous as well as pulmonary circulation. A combination radionuclide ascending venography with lung perfusion scan is a useful and reliable single test for this purpose.
Collapse
Affiliation(s)
- R Parakh
- Department of Vascular and Endovascular Surgery, Sir Ganga Ram Hospital, New Delhi, India.
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Kapadia S, Yadav A, Parakh R. Snapshots in surgery. Pulsatile scrotum. Br J Surg 2006; 93:1223. [PMID: 17078119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Affiliation(s)
- S Kapadia
- Department of Vascular and Endovascular Surgery, Sir Ganga Ram Hospital, New Delhi, India. rparakh1@ yahoo.com.in
| | | | | |
Collapse
|
36
|
Parazzini M, Hall AJ, Lutman ME, Kapadia S. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions. Hear Res 2006; 205:44-52. [PMID: 15953514 DOI: 10.1016/j.heares.2005.02.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2004] [Accepted: 02/28/2005] [Indexed: 11/21/2022]
Abstract
It is well known that aspirin consumption temporarily reduces overall otoacoustic emission (OAE) amplitude in humans. However, little is known about changes in the separate components of distortion product otoacoustic emissions (DPOAE), which may be distinguished by examining phase gradients. The effects of aspirin on the phase gradient of the DPOAE 2F1-F2 obtained with fixed frequency ratio sweeps were studied longitudinally in a group of twelve subjects in whom a temporary hearing loss was induced by aspirin consumption. DPOAE were recorded daily for two days pre-aspirin consumption, during the three days of aspirin consumption and two days afterwards. DP-grams were recorded over a restricted frequency range centered on 2,3,4 and 6 kHz with the following stimulus levels: L1/L2 of 60/50-80/70 in 10-dB steps. The effects of aspirin on the phase gradients varied between the subjects and across frequency: the general trend was that the phase gradient became steeper across successive sessions for the higher frequencies, while no significant effect was found at the lower frequencies. These results suggest that aspirin may have more persistent effects on cochlear function than are disclosed by measurements of hearing threshold level or DPOAE amplitude. Particularly, DPOAE phase gradient appears to be increased by aspirin consumption and has not recovered two days after cessation of aspirin intake, despite almost complete recovery of DPOAE amplitude and hearing threshold levels. These findings may suggest differential effects on the distortion and reflection mechanisms considered to underlie DPOAE generation.
Collapse
Affiliation(s)
- M Parazzini
- Istituto di Ingegneria Biomedica ISIB, CNR, Milan, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.
| | | | | | | |
Collapse
|
37
|
Sitges M, Kapadia S, Rubin DN, Thomas JD, Tuzcu ME, Lever HM. Percutaneous transluminal alcohol septal myocardial ablation after aortic valve replacement. Catheter Cardiovasc Interv 2001; 53:524-6. [PMID: 11515006 DOI: 10.1002/ccd.1215] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
When left ventricular outflow tract obstruction develops after aortic valve replacement, few treatment choices have been available until now. We present a patient with prior aortic valve replacement who developed left ventricle outflow tract obstruction that was successfully treated with a percutaneous transcoronary myocardial septal alcohol ablation. This technique is a useful tool for the treatment of obstructive hypertrophic cardiomyopathy, especially in those patients with prior heart surgery.
Collapse
Affiliation(s)
- M Sitges
- Cardiology Department, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
| | | | | | | | | | | |
Collapse
|
38
|
Abstract
We describe a case of lead poisoning due to herbal remedies, presenting with an acute abdomen, raised porphyrins and increased liver enzyme activities. We suggest that lead poisoning should be considered in the differential diagnosis of the 'acute abdomen', and that the presence of liver dysfunction points to the possibility of Asian herbal remedies as the source of the lead poisoning.
Collapse
Affiliation(s)
- N R Anderson
- Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK.
| | | | | |
Collapse
|
39
|
Doraiswamy B, Kapadia S, Kumar S. Disseminated deep tissue infection with draining sinus tracts in a healthy seven-year-old. Pediatr Infect Dis J 2001; 20:323-6. [PMID: 11303844 DOI: 10.1097/00006454-200103000-00026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- B Doraiswamy
- Department of Pediatrics, The Brooklyn Hospital Center, NY, USA
| | | | | |
Collapse
|
40
|
Abstract
The application of the maximum length sequence (MLS) technique to the recording of click-evoked otoacoustic emissions (CEOAEs) allows for a reduction in test time by one to two orders of magnitude. This is because the technique permits the use of extremely high click rates, as inter-click intervals are not constrained to be greater than the duration of the response. However, increasing the click rate also causes a progressive reduction in amplitude, or 'suppression', of the CEOAE. The origin of this suppression is unclear, with diverse suggestions in the literature as to its nature and mechanism. This paper presents a simple model of the well-known compressive non-linearity of the CEOAE level function, based on a static amplitude non-linearity within each of a number of narrowband frequency channels. The response of the model to MLS stimulation demonstrates suppression broadly of the form and magnitude previously reported in experimental studies. Furthermore, the model exhibits the generation of additional non-linear components that have been speculated on in connection with CEOAE recordings using the MLS technique. It is concluded that the MLS suppression phenomenon is derived largely, if not entirely, from the static non-linearity of the CEOAE level function. The approach to modelling the phenomenon as described here also bears promise for understanding various aspects of non-linearity in MLS-based CEOAE recordings.
Collapse
Affiliation(s)
- S Kapadia
- Institute of Sound and Vibration Research, University of Southampton, UK.
| | | |
Collapse
|
41
|
Abstract
p64 is a chloride channel of intracellular membranes which is present in regulated secretory vesicles. Mechanisms by which the p64 channel could be regulated are largely unknown. p59(fyn) is a non-receptor tyrosine kinase of the Src family that has been implicated in a variety of intracellular signaling events. The N-terminal portion of p64 has several potential binding sites for Src family SH2 domains. In this paper, we demonstrate that p64 becomes tyrosine phosphorylated when co-expressed with p59(fyn) in HeLa cells. We show that co-expression of p64 with p59(fyn) renders p64 a ligand for the SH2 domain of p59(fyn) and this SH2 binding is eliminated by treating p64 with alkaline phosphatase. Using site-directed mutagenesis, we find that tyrosine 33 in the p64 sequence is necessary for SH2 binding. We also characterized p64-p59(fyn) interactions using native material from bovine kidney. We found that a small fraction of native kidney p64 can bind Fyn SH2 in vitro. Immunoprecipitation of p64 from solubilized kidney membranes yields a kinase activity with the same mobility by SDS-polyacrylamide gel electrophoresis as authentic bovine p59(fyn). Finally, we demonstrate that co-expression of p64 and p59(fyn) in HeLa cells results in enhanced p64-associated chloride channel activity.
Collapse
Affiliation(s)
- J C Edwards
- Renal Division, Department of Medicine, St. Louis University and the St. Louis Veterans Affairs Medical Center, St. Louis, Missouri 63106, USA.
| | | |
Collapse
|
42
|
Abstract
Click-evoked otoacoustic emissions (CEOAEs) are reduced in amplitude by the presentation of 'suppressor' clicks that either closely lead or follow the stimulus ('test') clicks. This suppression of the response represents nonlinear temporal interactions between the test and suppressor clicks and/or the CEOAEs they evoke. There are some discrepancies amongst previous reports of the phenomenon, and the underlying mechanisms are not understood. In particular, it is unclear whether the suppression reported simply reflects the compressive nonlinearity of the CEOAE input-output (I-O) function. This paper presents a simple model of the nonlinear interactions between CEOAEs evoked by two closely-spaced clicks. The model shows that suppression as reported may be entirely derived from CEOAE I-O nonlinearity, in combination with the extended duration of the cochlear responses to click stimuli. It is also shown experimentally that suppression is insensitive to the polarities of test and suppressor clicks, which is consistent with the model based on I-O nonlinearity. A companion paper (Kapadia and Lutman, Hear. Res. 146 (2000)) presents experimental findings from a detailed parametric study of nonlinear temporal interactions in CEOAEs in human subjects with normal hearing. The findings are compared with the pattern of results generated by the above model, in order to assess the role of I-O nonlinearity in these nonlinear interactions.
Collapse
Affiliation(s)
- S Kapadia
- Institute of Sound and Vibration Research, University of Southampton, SO17 1BJ, Southampton, UK.
| | | |
Collapse
|
43
|
Abstract
Click-evoked otoacoustic emissions (CEOAEs) are reduced in amplitude by the presentation of 'suppressor' clicks that either closely lead or follow the stimulus ('test') clicks. A model described in a companion paper (Kapadia and Lutman, Hear. Res. 146 (2000) 89-100) shows that such nonlinear temporal interactions, as previously reported, may be explained in terms of the compressive non-linearity of the CEOAE input-output (I-O) function. This paper presents the results of a detailed parametric investigation into such nonlinear interactions, studied in 12 normal adult ears over a wide range of test and suppressor click levels and inter-click intervals. The results differ from those generated by the model in a number of respects. Principally, maximum suppression is generally obtained for suppressors presented in advance of test clicks, rather than co-incident with the test clicks. The amount of advance depends systematically on the two click levels. The measured suppression can also exceed the theoretical maximum allowed by the model. It is concluded that the nonlinear temporal interactions measured do not simply reflect CEOAE I-O function non-linearity. They may, instead, arise from disturbance of the generator elements from their resting state prior to generation of the CEOAE. These results may also have general implications relating to cochlear responses to transient stimuli and indicate the potential of CEOAEs in probing aspects of cochlear mechanics.
Collapse
Affiliation(s)
- S Kapadia
- Institute of Sound and Vibration Research, University of Southampton, SO17 1BJ, Southampton, UK.
| | | |
Collapse
|
44
|
Abstract
Correspondence between spectral patterns in otoacoustic emissions (OAE) and the fine structure of the pure-tone audiogram has often been noted, but the link is by no means clearly understood nor complete in all subjects. This paper presents part of a broader study focusing on individuals with normal hearing but anomalously weak OAEs, the primary purpose of which was to determine the reasons for the weak OAEs. Subjects were selected from an exhaustive search of some 400 ears of highly co-operative adults, and comprised a test group of subjects with normal hearing thresholds but weak OAEs, and a control group of normals from the same sample. Reported here are data on audiogram fine structure measured in the two groups of subjects. The basic finding is that the subjects with weak OAEs also exhibited significantly less audiogram fine structure than the controls, as evaluated by analysing the periodicity in the respective threshold curves as well as by identifying and quantifying individual peaks in the curves. These findings first provide further evidence of an underlying link between the fine structure of the audiogram and OAEs, as proposed by Kemp in his original work. Second, assuming that the degree of fine structure would be largely unaffected by minor middle ear alterations, our findings suggest that predominantly cochlear rather than middle ear factors are responsible for the low levels of OAEs in the normal subjects of our test group. Finally, the results presented suggest that, like OAEs, audiogram fine structure measurements provide information on the auditory system that is not available in the conventional pure-tone audiogram.
Collapse
Affiliation(s)
- S Kapadia
- Institute of Sound and Vibration Research, University of Southampton, UK
| | | |
Collapse
|
45
|
Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA, Vignery A. Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice. J Bone Miner Res 1999; 14:1067-74. [PMID: 10404006 DOI: 10.1359/jbmr.1999.14.7.1067] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The neuropeptide calcitonin gene-related peptide (CGRP) is concentrated in fine sensory nerve endings innervating all tissues, including bone. CGRP inhibits osteoclasts, stimulates insulin-like growth factor I and inhibits tumor necrosis factor alpha production by osteoblasts in vitro. To investigate the role of CGRP in bone in vivo, mice were engineered to express CGRP in osteoblasts by placing the human CGRP gene under the control of the rat osteocalcin promoter (Ost-CGRP tg+ mice). Calvaria cultures from transgene positive (tg+), but not tg- mice, produced bioactive CGRP. Trabecular bone density and bone volume, determined by peripheral quantitative computed tomography and bone histomorphometry, respectively, were higher in tg+ than tg- littermates. This increase in bone volume was associated with an increased bone formation rate. Trabecular bone density decreased in tg+ mice as a result of ovariectomy, but remained higher than in sham tg- mice. Targeting CGRP to osteoblasts appears to favor the establishment of a higher trabecular bone mass in mice.
Collapse
Affiliation(s)
- R Ballica
- Yale University School of Medicine, Department of Orthopaedics and Rehabilitation, New Haven, Connecticut 06510, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Kapadia NK, Kapadia S, Khayat A. Left main coronary artery patch angioplasty: follow-up with spiral computed tomography. Ann Thorac Surg 1999; 67:1211-2. [PMID: 10320296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
47
|
Ballal RS, Kapadia S, Secknus MA, Rubin D, Arheart K, Marwick TH. Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography. Am Heart J 1999; 137:469-75. [PMID: 10047628 DOI: 10.1016/s0002-8703(99)70494-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
BACKGROUND Coronary disease is an important cause of long-term morbidity in patients needing major vascular surgery. We sought to assess the efficacy of preoperative clinical evaluation and the detection of inducible ischemia for prediction of immediate and long-term cardiac outcomes of patients undergoing vascular surgery. METHODS In 233 patients undergoing vascular procedures, we assessed risk clinically on the basis of Eagle's criteria. Dobutamine echocardiography was performed with a standard protocol and results were classified as showing ischemia, scar, or a normal response. Patients were observed perioperatively, and late follow-up (28 +/- 13 months) was completed in all surgical survivors. A composite end point of cardiac death, myocardial infarction, and unstable and progressive angina requiring late revascularization was used to judge event-free survival. RESULTS Of 233 patients undergoing preoperative dobutamine echocardiography, 39 (17%) had inducible ischemia and 36 (15%) had scar. Perioperative events occurred in 8 patients (3%). None of the patients with ischemia had perioperative events, reflecting the effect of revascularization in 9 patients. Late events occurred in 36 patients; ischemia on preoperative stress testing was a predictor of these events even after adjusting for clinical variables and left ventricular dysfunction (relative risk = 3.3; 95% confidence interval 1.6 to 6.8; P =.001). The association of ischemia with clinical predictors was associated with incrementally worse outcome. CONCLUSION In addition to perioperative assessment, the combined use of clinical and dobutamine echocardiographic evaluation may stratify the risk of late cardiac events.
Collapse
Affiliation(s)
- R S Ballal
- Cleveland Clinic Foundation, Cleveland, OH, USA
| | | | | | | | | | | |
Collapse
|
48
|
Gendeh BS, Ferguson BJ, Johnson JT, Kapadia S. Progressive septal and palatal perforation secondary to intranasal cocaine abuse. Med J Malaysia 1998; 53:435-8. [PMID: 10971991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
Septal perforation from intranasal cocaine abuse is well recognised. We present a case of progressive septal as well as palatal perforation. Progression from septal perforation to palatal perforation occurred after cessation of intranasal cocaine abuse. This patient had a weakly positive cytoplasmic antineutrophilic cytoplasmic antibody (C-ANCA) but no histologic evidence of Wegener's Granulomatosis. The differential diagnosis for septal and palatal perforation is reviewed. This case represents the fifth reported case of palatal perforation secondary to cocaine abuse in the literature, and the second associated with positive C-ANCA.
Collapse
Affiliation(s)
- B S Gendeh
- Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Hospital National University of Malaysia, Kuala Lumpur
| | | | | | | |
Collapse
|
49
|
Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL. The role of cytokines in the failing human heart. Cardiol Clin 1998; 16:645-56, viii. [PMID: 9891594 DOI: 10.1016/s0733-8651(05)70041-2] [Citation(s) in RCA: 69] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Despite repeated attempts to develop a unifying hypothesis that explains the clinical syndrome of heart failure, no single conceptual paradigm has withstood the test of time. In this regard, recent studies have shown that a class of biologically active molecules, generically referred to as cytokines, are overexposed in heart failure. This article will review recent clinical and experimental material that suggest proinflammatory (stress activated) cytokines such as tumor necrosis factor-alpha (TFN-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6) may play a role in the pathogenesis of congestive heart failure. The scope of this article includes an overview of the biology of cytokines in the heart, as well as review of the clinical studies that have documented elevated levels of cytokines and cytokine receptors in patients with heart failure.
Collapse
Affiliation(s)
- S Kapadia
- Department of Medicine, Veterans Administration Medical Center, Houston, Texas, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
Cutaneous wound healing in the fetus can occur in a nonfibrotic, regenerative manner. However, other fetal tissues such as bone and stomach heal with scar formation. In light of potential ramifications for adult hollow visceral scarring (biliary and intestinal strictures), this study was undertaken to determine if tubular visceral tissue repair in the fetus is regenerative or fibrotic. Fetal rabbits underwent laparotomy on day 24 of gestation, during which a controlled intestinal enterotomy was created and suture repaired immediately using microsurgical techniques. Maternal rabbits and adult male rabbits also underwent enterotomy and repair. After 5 days all animals were sacrificed and the wounds analyzed histologically by a pathologist in a blinded fashion. All animals demonstrated a similar degree of peri-intestinal adhesion formation. Fetal and maternal wounds contained fibroblastic and smooth muscle cell proliferation, mild inflammatory infiltration, and new blood vessel formation. The male adult wounds demonstrated a more pronounced fibrovascular healing response. Immunohistochemical staining for CD31 (endothelial cell marker) was quantitated on a scale of 0 to 4+, indicating degree of neovascularization. The mean scores for the fetal and maternal groups were similar (1.70 +/- 0.68 and 1.23 +/- 1.07 respectively), but were significantly greater for male adults (2.93 +/- 0.12; p = 0.001 by analysis of variance). The results of this study indicate that hollow visceral tissue repair in the fetal rabbit intestine occurs in a similar fibrotic manner as adult healing. This provides further evidence that regenerative healing in the fetus is not ubiquitous. Differences in the degrees of fibrosis and neovascularization between adult male and pregnant female wounds deserve further investigation.
Collapse
Affiliation(s)
- B A Mast
- Division of Plastic and Reconstructive Surgery, University of Florida, Gainesville 32606, USA
| | | | | |
Collapse
|